×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Microglial Metabolic Reprogramming
mechanism
1,360 words
KG: Microglial Metabolic Reprogramming
2026-04-01
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
Microglial Metabolic Reprogramming
⚙
Mechanism Info
Name
Microglial Metabolic Reprogramming
Summary
Fixed References and See Also
Key Genes/Proteins
HIF1A
Linked Hypotheses
2 hypotheses
Knowledge Graph
Related Hypotheses (30)
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Epigenetic Memory Reprogramming for Alzheimer's Disease
Score: 0.47
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.45
Microbial Inflammasome Priming Prevention
Score: 0.58
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P
Score: 0.64
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming
Score: 0.59
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Disease-Associated Microglia Metabolic Reprogramming
Score: 0.50
Orexin-Microglia Modulation Therapy
Score: 0.49
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.48
APOE-TREM2 Interaction Modulation
Score: 0.48
Circadian-Metabolic Microglial Reprogramming
Score: 0.46
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in
Score: 0.46
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
APOE-Dependent Autophagy Restoration
Score: 0.61
Digital Twin-Guided Metabolic Reprogramming
Score: 0.61
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromat
Score: 0.52
Mechanosensitive Ion Channel Reprogramming
Score: 0.51
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio
Score: 0.49
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Show 25 more
Related Experiments (12)
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88
iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46
Acteoside treatment in LPS-induced SALI mouse model
validation · proposed · Score: 0.90
Nrf2 inhibitor ML385 mechanism validation experiment
exploratory · proposed · Score: 0.85
Acteoside effects on RAW264.7 macrophage cells
exploratory · proposed · Score: 0.85
Show 7 more
Knowledge Graph (1 edges)
HIF1A
associated_with
Microglial Metabolic Reprogramming